CA2629465A1 - Methode de detection et/ou d'isolation de mycobacteries - Google Patents

Methode de detection et/ou d'isolation de mycobacteries Download PDF

Info

Publication number: CA2629465A1
Authority: CA; Canada
Prior art keywords: mycobacteria; sample; seq; pcr; detection
Prior art date: 2007-04-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002629465A

Other languages

English (en)

Inventor

Christoph Kluge

Gilles Marchal

Maria-Cristina Gutierrez Perez

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CENTRE D'ANALYSES ENVIRONNEMENTALES (CAE)

Institut Pasteur

Original Assignee

CENTRE D'ANALYSES ENVIRONNEMENTALES (CAE)

Institut Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-19

Filing date

2008-04-18

Publication date

2008-10-19

2007-04-19 Priority claimed from CA 2585670 external-priority patent/CA2585670A1/fr

2008-04-18 Application filed by CENTRE D'ANALYSES ENVIRONNEMENTALES (CAE), Institut Pasteur filed Critical CENTRE D'ANALYSES ENVIRONNEMENTALES (CAE)

2008-04-18 Priority to CA002629465A priority Critical patent/CA2629465A1/fr

2008-10-19 Publication of CA2629465A1 publication Critical patent/CA2629465A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 112
238000001514 detection method Methods 0.000 claims abstract description 43
201000008827 tuberculosis Diseases 0.000 claims abstract description 11
239000011324 bead Substances 0.000 claims description 87
241001508003 Mycobacterium abscessus Species 0.000 claims description 37
241000186359 Mycobacterium Species 0.000 claims description 34
238000003753 real-time PCR Methods 0.000 claims description 34
230000005291 magnetic effect Effects 0.000 claims description 29
238000002360 preparation method Methods 0.000 claims description 23
241000186367 Mycobacterium avium Species 0.000 claims description 17
241000186363 Mycobacterium kansasii Species 0.000 claims description 13
241000283973 Oryctolagus cuniculus Species 0.000 claims description 13
230000033001 locomotion Effects 0.000 claims description 13
241000187484 Mycobacterium gordonae Species 0.000 claims description 12
238000001914 filtration Methods 0.000 claims description 12
241000187494 Mycobacterium xenopi Species 0.000 claims description 11
239000003795 chemical substances by application Substances 0.000 claims description 8
230000035899 viability Effects 0.000 claims description 7
210000002421 cell wall Anatomy 0.000 claims description 6
230000004544 DNA amplification Effects 0.000 claims description 5
238000002965 ELISA Methods 0.000 claims description 5
206010036790 Productive cough Diseases 0.000 claims description 4
238000000386 microscopy Methods 0.000 claims description 4
239000008267 milk Substances 0.000 claims description 4
210000004080 milk Anatomy 0.000 claims description 4
235000013336 milk Nutrition 0.000 claims description 4
238000007899 nucleic acid hybridization Methods 0.000 claims description 4
210000003802 sputum Anatomy 0.000 claims description 4
208000024794 sputum Diseases 0.000 claims description 4
238000010186 staining Methods 0.000 claims description 4
102100029714 DnaJ homolog subfamily B member 2 Human genes 0.000 claims description 3
101000866020 Homo sapiens DnaJ homolog subfamily B member 2 Proteins 0.000 claims description 3
238000002105 Southern blotting Methods 0.000 claims description 3
238000007399 DNA isolation Methods 0.000 claims description 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
241001467552 Mycobacterium bovis BCG Species 0.000 claims 1
238000002955 isolation Methods 0.000 abstract description 16
230000007613 environmental effect Effects 0.000 abstract description 12
239000000523 sample Substances 0.000 description 127
241000894006 Bacteria Species 0.000 description 63
108020004414 DNA Proteins 0.000 description 52
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 50
238000003556 assay Methods 0.000 description 41
238000011534 incubation Methods 0.000 description 34
241000894007 species Species 0.000 description 24
238000006243 chemical reaction Methods 0.000 description 21
101150087539 sodA gene Proteins 0.000 description 20
238000004458 analytical method Methods 0.000 description 16
238000003312 immunocapture Methods 0.000 description 16
230000035945 sensitivity Effects 0.000 description 15
101150017120 sod gene Proteins 0.000 description 15
101150018269 sodB gene Proteins 0.000 description 15
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
238000002649 immunization Methods 0.000 description 13
108090000623 proteins and genes Proteins 0.000 description 13
229920001213 Polysorbate 20 Polymers 0.000 description 12
239000000872 buffer Substances 0.000 description 12
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 12
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 12
230000001580 bacterial effect Effects 0.000 description 11
210000002966 serum Anatomy 0.000 description 11
239000008399 tap water Substances 0.000 description 11
235000020679 tap water Nutrition 0.000 description 11
238000012360 testing method Methods 0.000 description 11
210000004027 cell Anatomy 0.000 description 8
238000010790 dilution Methods 0.000 description 8
239000012895 dilution Substances 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
230000003321 amplification Effects 0.000 description 7
239000000427 antigen Substances 0.000 description 7
108091007433 antigens Proteins 0.000 description 7
102000036639 antigens Human genes 0.000 description 7
239000012141 concentrate Substances 0.000 description 7
238000005859 coupling reaction Methods 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
230000014509 gene expression Effects 0.000 description 7
238000003199 nucleic acid amplification method Methods 0.000 description 7
239000000047 product Substances 0.000 description 7
238000011002 quantification Methods 0.000 description 7
239000011543 agarose gel Substances 0.000 description 6
230000008878 coupling Effects 0.000 description 6
238000010168 coupling process Methods 0.000 description 6
238000010998 test method Methods 0.000 description 6
238000011282 treatment Methods 0.000 description 6
108091093088 Amplicon Proteins 0.000 description 5
108700039887 Essential Genes Proteins 0.000 description 5
238000000576 coating method Methods 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
239000000463 material Substances 0.000 description 5
239000012528 membrane Substances 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 4
108020004711 Nucleic Acid Probes Proteins 0.000 description 4
238000002944 PCR assay Methods 0.000 description 4
208000026681 Paratuberculosis Diseases 0.000 description 4
108010012715 Superoxide dismutase Proteins 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
238000004364 calculation method Methods 0.000 description 4
239000011248 coating agent Substances 0.000 description 4
238000009826 distribution Methods 0.000 description 4
101150086609 groEL2 gene Proteins 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000002844 melting Methods 0.000 description 4
230000008018 melting Effects 0.000 description 4
244000005700 microbiome Species 0.000 description 4
239000000203 mixture Substances 0.000 description 4
239000002853 nucleic acid probe Substances 0.000 description 4
150000007523 nucleic acids Chemical class 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 3
241000192125 Firmicutes Species 0.000 description 3
241000282412 Homo Species 0.000 description 3
101150005343 INHA gene Proteins 0.000 description 3
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
241000187495 Mycobacterium terrae Species 0.000 description 3
241000187479 Mycobacterium tuberculosis Species 0.000 description 3
241000316848 Rhodococcus <scale insect> Species 0.000 description 3
102000019197 Superoxide Dismutase Human genes 0.000 description 3
230000004913 activation Effects 0.000 description 3
238000013459 approach Methods 0.000 description 3
JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000009260 cross reactivity Effects 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
239000000539 dimer Substances 0.000 description 3
235000020188 drinking water Nutrition 0.000 description 3
239000003651 drinking water Substances 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
239000012634 fragment Substances 0.000 description 3
230000036541 health Effects 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
239000007788 liquid Substances 0.000 description 3
-1 p-toluenesulphonyl (tosyl) reactive groups Chemical group 0.000 description 3
230000005298 paramagnetic effect Effects 0.000 description 3
230000001717 pathogenic effect Effects 0.000 description 3
239000008188 pellet Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
230000009257 reactivity Effects 0.000 description 3
238000011084 recovery Methods 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
101150058734 A gene Proteins 0.000 description 2
101100489581 Caenorhabditis elegans par-5 gene Proteins 0.000 description 2
101100353517 Caenorhabditis elegans pas-2 gene Proteins 0.000 description 2
241000589875 Campylobacter jejuni Species 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
206010062207 Mycobacterial infection Diseases 0.000 description 2
241001502334 Mycobacterium avium complex bacterium Species 0.000 description 2
241000157299 Mycobacterium branderi Species 0.000 description 2
241000187478 Mycobacterium chelonae Species 0.000 description 2
241000186362 Mycobacterium leprae Species 0.000 description 2
241001302239 Mycobacterium tuberculosis complex Species 0.000 description 2
241000187654 Nocardia Species 0.000 description 2
108091028043 Nucleic acid sequence Proteins 0.000 description 2
108010037490 Peptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 4 Proteins 0.000 description 2
102100031653 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 Human genes 0.000 description 2
238000011529 RT qPCR Methods 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
238000000137 annealing Methods 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000012468 concentrated sample Substances 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000005202 decontamination Methods 0.000 description 2
230000003588 decontaminative effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
239000000975 dye Substances 0.000 description 2
238000009585 enzyme analysis Methods 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
101150013736 gyrB gene Proteins 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
238000011430 maximum method Methods 0.000 description 2
239000011325 microbead Substances 0.000 description 2
230000002906 microbiologic effect Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
208000027531 mycobacterial infectious disease Diseases 0.000 description 2
244000052769 pathogen Species 0.000 description 2
230000007918 pathogenicity Effects 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
DXHWIAMGTKXUEA-UHFFFAOYSA-O propidium monoazide Chemical compound C12=CC(N=[N+]=[N-])=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 DXHWIAMGTKXUEA-UHFFFAOYSA-O 0.000 description 2
238000012207 quantitative assay Methods 0.000 description 2
238000004062 sedimentation Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000004611 spectroscopical analysis Methods 0.000 description 2
230000008685 targeting Effects 0.000 description 2
108700026220 vif Genes Proteins 0.000 description 2
238000003260 vortexing Methods 0.000 description 2
238000005406 washing Methods 0.000 description 2
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
101150021183 65 gene Proteins 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
101150076489 B gene Proteins 0.000 description 1
108020000946 Bacterial DNA Proteins 0.000 description 1
101710098119 Chaperonin GroEL 2 Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010054814 DNA Gyrase Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241001646719 Escherichia coli O157:H7 Species 0.000 description 1
101100180305 Escherichia coli iss gene Proteins 0.000 description 1
QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
102000020897 Formins Human genes 0.000 description 1
108091022623 Formins Proteins 0.000 description 1
108010004889 Heat-Shock Proteins Proteins 0.000 description 1
102000002812 Heat-Shock Proteins Human genes 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
101150093453 LSS gene Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241000187475 Mycobacterium aichiense Species 0.000 description 1
241000957223 Mycobacterium alvei Species 0.000 description 1
241000187474 Mycobacterium asiaticum Species 0.000 description 1
241000187473 Mycobacterium aurum Species 0.000 description 1
241001532520 Mycobacterium austroafricanum Species 0.000 description 1
241001316387 Mycobacterium boenickei Species 0.000 description 1
241000186366 Mycobacterium bovis Species 0.000 description 1
241000634333 Mycobacterium bovis AF2122/97 Species 0.000 description 1
241001316365 Mycobacterium brisbanense Species 0.000 description 1
241001674312 Mycobacterium brumae Species 0.000 description 1
241000318680 Mycobacterium canariasense Species 0.000 description 1
241001312372 Mycobacterium canettii Species 0.000 description 1
241001134667 Mycobacterium celatum Species 0.000 description 1
241000187472 Mycobacterium chitae Species 0.000 description 1
241001524108 Mycobacterium chlorophenolicum Species 0.000 description 1
241000187913 Mycobacterium chubuense Species 0.000 description 1
241001134628 Mycobacterium confluentis Species 0.000 description 1
241000187487 Mycobacterium cookii Species 0.000 description 1
241001420379 Mycobacterium cosmeticum Species 0.000 description 1
241000587727 Mycobacterium doricum Species 0.000 description 1
241000187471 Mycobacterium fallax Species 0.000 description 1
241001420342 Mycobacterium fluoranthenivorans Species 0.000 description 1
241000186365 Mycobacterium fortuitum Species 0.000 description 1
241001509451 Mycobacterium genavense Species 0.000 description 1
241000202700 Mycobacterium hassiacum Species 0.000 description 1
241000142650 Mycobacterium heckeshornense Species 0.000 description 1
241000245945 Mycobacterium hodleri Species 0.000 description 1
241001644172 Mycobacterium holsaticum Species 0.000 description 1
241000516643 Mycobacterium kubicae Species 0.000 description 1
241000439014 Mycobacterium lacus Species 0.000 description 1
241001248583 Mycobacterium lentiflavum Species 0.000 description 1
241000432069 Mycobacterium leprae TN Species 0.000 description 1
241000187493 Mycobacterium malmoense Species 0.000 description 1
241000187492 Mycobacterium marinum Species 0.000 description 1
241000557009 Mycobacterium mucogenicum Species 0.000 description 1
241001062465 Mycobacterium murale Species 0.000 description 1
241000987219 Mycobacterium neglectum Species 0.000 description 1
241000611872 Mycobacterium novocastrense Species 0.000 description 1
241000187918 Mycobacterium obuense Species 0.000 description 1
241001101480 Mycobacterium parmense Species 0.000 description 1
241001532510 Mycobacterium poriferae Species 0.000 description 1
241001509447 Mycobacterium pulveris Species 0.000 description 1
241001509458 Mycobacterium rhodesiae Species 0.000 description 1
241000224454 Mycobacterium saskatchewanense Species 0.000 description 1
241000187490 Mycobacterium scrofulaceum Species 0.000 description 1
241000187489 Mycobacterium simiae Species 0.000 description 1
241001025881 Mycobacterium smegmatis str. MC2 155 Species 0.000 description 1
241000187477 Mycobacterium thermoresistibile Species 0.000 description 1
241001532502 Mycobacterium tokaiense Species 0.000 description 1
241000187476 Mycobacterium triviale Species 0.000 description 1
101000944608 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Chaperonin GroEL 2 Proteins 0.000 description 1
241001293520 Mycobacterium tusciae Species 0.000 description 1
241000187917 Mycobacterium ulcerans Species 0.000 description 1
241000187644 Mycobacterium vaccae Species 0.000 description 1
241000611277 Mycobacterium wolinskyi Species 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
101710123661 Venom allergen 5 Proteins 0.000 description 1
101000832077 Xenopus laevis Dapper 1-A Proteins 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
KSCQDDRPFHTIRL-UHFFFAOYSA-N auramine O Chemical compound [H+].[Cl-].C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 KSCQDDRPFHTIRL-UHFFFAOYSA-N 0.000 description 1
238000003766 bioinformatics method Methods 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
229940015062 campylobacter jejuni Drugs 0.000 description 1
230000008859 change Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000011143 downstream manufacturing Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
238000005286 illumination Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000003316 immunomagnetic separation method Methods 0.000 description 1
238000013383 initial experiment Methods 0.000 description 1
238000010872 live dead assay kit Methods 0.000 description 1
239000006166 lysate Substances 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000011880 melting curve analysis Methods 0.000 description 1
238000005555 metalworking Methods 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
101150012629 parE gene Proteins 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
238000004094 preconcentration Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
150000003141 primary amines Chemical group 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000005180 public health Effects 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
229940043267 rhodamine b Drugs 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
239000002689 soil Substances 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
238000012800 visualization Methods 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Cell Biology (AREA)
Tropical Medicine & Parasitology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA002629465A 2007-04-19 2008-04-18 Methode de detection et/ou d'isolation de mycobacteries Abandoned CA2629465A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA002629465A CA2629465A1 (fr)	2007-04-19	2008-04-18	Methode de detection et/ou d'isolation de mycobacteries

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
CA 2585670 CA2585670A1 (fr)	2007-04-19	2007-04-19	Methode de detection des mycobacteries non tuberculeuses
CA2,585,670		2007-04-19
CA002618289A CA2618289A1 (fr)	2007-04-19	2008-01-21	Methode de detection des mycobacteries non tuberculeuses
CA2,618,289		2008-01-21
CA002629465A CA2629465A1 (fr)	2007-04-19	2008-04-18	Methode de detection et/ou d'isolation de mycobacteries

Publications (1)

Publication Number	Publication Date
CA2629465A1 true CA2629465A1 (fr)	2008-10-19

Family

ID=39720352

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA002618289A Abandoned CA2618289A1 (fr)	2007-04-19	2008-01-21	Methode de detection des mycobacteries non tuberculeuses
CA002629465A Abandoned CA2629465A1 (fr)	2007-04-19	2008-04-18	Methode de detection et/ou d'isolation de mycobacteries

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA002618289A Abandoned CA2618289A1 (fr)	2007-04-19	2008-01-21	Methode de detection des mycobacteries non tuberculeuses

Country Status (3)

Country	Link
EP (1)	EP2145017A2 (fr)
CA (2)	CA2618289A1 (fr)
WO (1)	WO2008129419A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2270202A1 (fr) *	2009-07-03	2011-01-05	John Ikonomopoulos	Détection mycobactérienne
EP2629095A1 (fr) *	2012-02-17	2013-08-21	Biosure R & T Cell Co.	Détection de cibles de protéine mycobactérienne incluant des points Quantum et séparation immunomagnétique
EP3052650B1 (fr)	2013-10-01	2019-04-03	The University Of Nottingham	Détection de mycobactéries a l'aide de bactériophages
WO2017077999A1 (fr) *	2015-11-06	2017-05-11	公立大学法人横浜市立大学	Procédé de détection d'adn dérivé du complexe tuberculosis
CN106290864A (zh) *	2016-08-12	2017-01-04	江苏泽成生物技术有限公司	一种人类免疫缺陷病毒抗原及抗体测定试剂盒及制备方法
CN109468316B (zh) *	2018-12-10	2020-06-05	上海市肺科医院	一种基因序列组合物及其在制备分枝杆菌肺病检测试剂盒中的应用
CN112574885A (zh) *	2019-09-29	2021-03-30	广东体必康生物科技有限公司	一种基于磁珠富集痰液样本的结核分枝杆菌检测方法及其专用试剂盒
CN116837119A (zh) *	2022-03-25	2023-10-03	湖州申科生物技术股份有限公司	检测分枝杆菌dna的引物及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2158854T3 (es) *	1992-10-13	2001-09-16	Hoffmann La Roche	Oligonucleotidos derivados de la familia de genes sod.
AT501194A1 (de) *	2004-12-30	2006-07-15	Thomas Dr Schlederer	Verfahren zur isolierung von zellen und viren
FR2890978B1 (fr) *	2005-09-20	2012-08-17	Hospices Civils Lyon	Procede de detection, dans un echantillon biologique de mycobacteries, et en particulier de mycobacteries caracteristiques de la tuberculose.

2008
- 2008-01-21 CA CA002618289A patent/CA2618289A1/fr not_active Abandoned
- 2008-04-18 CA CA002629465A patent/CA2629465A1/fr not_active Abandoned
- 2008-04-21 WO PCT/IB2008/001255 patent/WO2008129419A2/fr not_active Ceased
- 2008-04-21 EP EP08750988A patent/EP2145017A2/fr not_active Withdrawn

Also Published As

Publication number	Publication date
WO2008129419A2 (fr)	2008-10-30
WO2008129419A3 (fr)	2009-04-30
CA2618289A1 (fr)	2008-10-19
EP2145017A2 (fr)	2010-01-20

Publication	Publication Date	Title
Pfyffer et al.	1996	Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens
Stanley et al.	2007	Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours
CA2629465A1 (fr)	2008-10-19	Methode de detection et/ou d'isolation de mycobacteries
Antonenka et al.	2013	Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens
Chikamatsu et al.	2014	Comparative evaluation of three immunochromatographic identification tests for culture confirmation of Mycobacterium tuberculosis complex
Modi et al.	2016	Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis
Yang et al.	2021	Rapid and visual differentiation of Mycobacterium tuberculosis from the Mycobacterium tuberculosis complex using multiplex loop-mediated isothermal amplification coupled with a nanoparticle-based lateral flow biosensor
US20180016623A1 (en)	2018-01-18	Compositions and methods for detecting nucleic acids in sputum
Jung et al.	2016	Evaluation of three real-time PCR assays for differential identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria species in liquid culture media
Phetsuksiri et al.	2020	Comparison of loop-mediated isothermal amplification, microscopy, culture, and PCR for diagnosis of pulmonary tuberculosis
Hosseiniporgham et al.	2022	A rapid phage assay for detection of viable Mycobacterium avium subsp. paratuberculosis in milk
Li et al.	1996	Rapid detection of Mycobacterium avium in stool samples from AIDS patients by immunomagnetic PCR
Bi et al.	2012	A rapid loop-mediated isothermal amplification assay targeting hspX for the detection of Mycobacterium tuberculosis complex
Ramos et al.	2016	Capilia™ TB-Neo assay: a new tool for rapid distinction between tuberculous and non-tuberculous mycobacteria
Alli et al.	2011	Direct molecular detection of Mycobacterium tuberculosis complex from clinical samples–An adjunct to cultural method of laboratory diagnosis of tuberculosis
Cho et al.	2011	Comparison of diagnostic performance of three real-time PCR kits for detecting Mycobacterium species
Tabibnejad et al.	2016	The optimization of molecular detection of clinical isolates of Brucella in blood cultures by eryD transcriptase gene for confirmation of culture-negative samples
Yousef	2008	Detection of bacterial pathogens in different matrices: current practices and challenges
Restrepo et al.	2006	Selective enrichment and detection of mycobacterial DNA in paucibacillary specimens
CN1914334B (zh)	2012-05-16	检测结核分枝杆菌的引物对及试剂盒
Hofmann-Thiel et al.	2010	Evaluation of the hyplex® TBC PCR test for detection of Mycobacterium tuberculosis complex in clinical samples
Oh et al.	2001	Improved detection and differentiation of mycobacteria with combination of Mycobacterium Growth Indicator Tube and Roche COBAS AMPLICOR System in conjunction with Duplex PCR
Adhikari et al.	2009	Loop-mediated isothermal amplification (LAMP) for the direct detection of human pulmonary infections with environmental (nontuberculosis) mycobacteria
García-Elorriaga et al.	2009	Clinical usefulness of the nested polymerase chain reaction in the diagnosis of extrapulmonary tuberculosis
Roberts et al.	2012	Comparison of the MGIT TBc immunochromatographic assay with the Accuprobe Gen-Probe TB assay for identification of Mycobacterium tuberculosis complex: results from a low-burden tuberculosis setting

Legal Events

Date	Code	Title	Description
2012-04-18	FZDE	Dead